Lung Cancer: Targets and Therapy, Volume 15, Issue (2024)

Browse this journal

Lung Cancer: Targets and Therapy, Volume 15, Issue (2024)

See all volumes and issues
Volume 15, 2024 Vol 14, 2023 Vol 13, 2022 Vol 12, 2021 Vol 11, 2020 Vol 10, 2019 Vol 9, 2018 Vol 8, 2017 Vol 7, 2016 Vol 6, 2015 Vol 5, 2014 Vol 4, 2013 Vol 3, 2012 Vol 2, 2011 Vol 1, 2010
Download citations Download PDFs Download issue

Issue In Progress

COMMENTARY

Article Commentary
“ACHILLES” Heel No More? Afatinib at 40 Mg Once Daily is Superior to Platinum-Based Chemotherapy in EGFR Uncommon (G719X, S768I, and L861Q) Mutations (ACHILLES/TORG1834)
Faustine X Luo & Sai-Hong Ignatius Ou
Pages: 69-73
Published online: 18 May 2024
Abstractfor“ACHILLES” Heel No More? Afatinib at 40 Mg Once Daily is Superior to Platinum-Based Chemotherapy in EGFR Uncommon (G719X, S768I, and L861Q) Mutations (ACHILLES/TORG1834) | Full Text | References | PDF (301.4 KB) | EPUB
  • 0 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer
Maria González-Cao, Xueting Cai, Jilian Wilhelmina Paulina Bracht, Xuan Han, Yang Yang, Carlos Pedraz-Valdunciel, Teresa Morán, Javier García-Corbacho, Andrés Aguilar, Reyes Bernabé, Pedro De Marchi, Luciane Sussuchi da Silva, Leticia Ferro Leal, Rui Manuel Reis, Jordi Codony-Servat, Eloisa Jantus-Lewintre, Miguel Angel Molina-Vila, Peng Cao & Rafael Rosell
Pages: 55-67
Published online: 09 May 2024
AbstractforHMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer | Full Text | References | PDF (5.2 MB) | EPUB
  • 29 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

COMMENTARY

Article Commentary
The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions
Dalia Kaakour & Misako Nagasaka
Pages: 49-54
Published online: 23 Apr 2024
AbstractforThe Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions | Full Text | References | PDF (335.3 KB) | EPUB
  • 64 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article Commentary
MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?
Danielle Brazel & Misako Nagasaka
Pages: 41-47
Published online: 12 Apr 2024
AbstractforMARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting? | Full Text | References | PDF (350.4 KB) | EPUB
  • 492 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study
Xue-Jun Dou, Run-Yang Ma, De-Wang Ren, Qiang Liu & Peng Yan
Pages: 29-40
Published online: 25 Mar 2024
AbstractforEffectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study | Full Text | References | PDF (4.4 MB) | EPUB
  • 55 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

PERSPECTIVES

Article Commentary
Overcoming Central β-Sheet #6 (Cβ6) ALK Mutation (L1256F), TP53 Mutations and Short Forms of EML4-ALK v3/b and v5a/b Splice Variants are the Unmet Need That a Re-Imagined 5th-Generation (5G) ALK TKI Must Deliver
Alexandria TM Lee & Sai-Hong Ignatius Ou
Pages: 19-27
Published online: 27 Feb 2024
AbstractforOvercoming Central β-Sheet #6 (Cβ6) ALK Mutation (L1256F), TP53 Mutations and Short Forms of EML4-ALK v3/b and v5a/b Splice Variants are the Unmet Need That a Re-Imagined 5th-Generation (5G) ALK TKI Must Deliver | Full Text | References | PDF (903 KB) | EPUB
  • 73 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Innovative Techniques in Video-Assisted Thoracoscopic Surgery: Lu’s Approach
Baofeng Wang, Jiang Wang, Tongyu Sun, Yilin Ding, Shasha Li & Hengxiao Lu
Pages: 9-17
Published online: 01 Feb 2024
AbstractforInnovative Techniques in Video-Assisted Thoracoscopic Surgery: Lu’s Approach | Full Text | References | PDF (1.2 MB) | EPUB
  • 71 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

COMMENTARY

Article Commentary
The Nail in the Coffin?: Examining the KEYNOTE-789 Clinical Trial’s Impact
Zhaohui Liao Arter & Misako Nagasaka
Pages: 1-8
Published online: 25 Jan 2024
AbstractforThe Nail in the Coffin?: Examining the KEYNOTE-789 Clinical Trial’s Impact | Full Text | References | PDF (368.6 KB) | EPUB
  • 139 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

“ACHILLES” Heel No More? Afatinib at 40 Mg Once Daily is Superior to Platinum-Based Chemotherapy in EGFR Uncommon (G719X, S768I, and L861Q) Mutations (ACHILLES/TORG1834)
Faustine X Luo et al.
Article Commentary | Published online: 18 May 2024
Open Access
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer
Maria González-Cao et al.
Article | Published online: 9 May 2024
Open Access
The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions
Dalia Kaakour et al.
Article Commentary | Published online: 23 Apr 2024
Open Access
MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?
Danielle Brazel et al.
Article Commentary | Published online: 12 Apr 2024
Open Access